Figure 6. Schematic illustration of site-specific conjugation strategies for ADCs, including (A) copper-catalyzed azide-alkynine cycloaddition, (B) oxime bond formation, and (С) Diels-Alder cycloaddition, providing selective and stable drug-antibody coupling [105] (CC BY-SA 4.0).